Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin Dosing in Cirrhotic Patients with Portal Hypertension
NCT07459972Phase 4Completed
- Sponsor
- Kafrelsheikh University
- Start
- Mar 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of simvastatin in Liver cirrhosis (LC), Portal Hypertension (PH), sponsored by Kafrelsheikh University. Started Mar 2024; status: completed.
02
Drugs
simvastatin
03
Conditions
Liver cirrhosis (LC)Portal Hypertension (PH)
Beyond the preview
Go deeper on NCT07459972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07459972.